Only a small percentage (10–20%) of early-stage HCC cases exhibit abnormal AFP serum levels, and patients with active liver inflammation may present false-positive AFP results (European Association for the Study of the Liver, 2018; Johnson et al., 2022). Here, AFP is linked to hepatocellular carcinoma.